Published in J Pediatr Rehabil Med on October 20, 2017
The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer (2007) 5.28
Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med (2002) 4.75
Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 4.22
Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2012) 3.01
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax (2011) 2.84
Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2012) 2.75
Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care (2007) 2.22
Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med (2009) 2.17
Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2002) 2.15
Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol (2007) 2.12
Vesicoureteral reflux in children with urachal anomalies. J Pediatr Urol (2011) 2.06
Quality assessment of economic analyses in pediatric urology. Urology (2013) 2.04
Urachal anomalies: a longitudinal study of urachal remnants in children and adults. J Urol (2007) 1.99
Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer (2007) 1.93
Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A (2008) 1.84
Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol (2002) 1.82
GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol (2007) 1.67
Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak (2010) 1.66
Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol (2005) 1.64
TNXB mutations can cause vesicoureteral reflux. J Am Soc Nephrol (2013) 1.59
Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Clin Cancer Res (2006) 1.58
Shock wave lithotripsy vs ureteroscopy: variation in surgical management of kidney stones at freestanding children's hospitals. J Urol (2012) 1.53
Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux. J Urol (2010) 1.53
Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics (2009) 1.52
Prospective measurement of patient exposure to radiation during pediatric ureteroscopy. J Urol (2012) 1.52
Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder. Infect Immun (2013) 1.50
The current state of surgical practice for neonatal torsion: a survey of pediatric urologists. J Pediatr Urol (2013) 1.46
Health risk behaviors among young adults with spina bifida. Dev Med Child Neurol (2012) 1.46
The effect of dietary sodium and fructose intake on urine and serum parameters of stone formation in a pediatric mouse model: a pilot study. J Urol (2013) 1.44
Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer. Urology (2012) 1.44
Radiation dose and screening for vesicoureteral reflux. AJR Am J Roentgenol (2010) 1.39
Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics (2008) 1.31
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer (2004) 1.29
Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer. J Urol (2006) 1.28
Randomized, controlled trial of spaced education to urology residents in the United States and Canada. J Urol (2007) 1.24
UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan. J Clin Oncol (2007) 1.20
Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial. Dermatoendocrinol (2012) 1.17
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors. Clin Cancer Res (2003) 1.17
Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. J Pediatr (2007) 1.15
Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Pediatr Pulmonol (2002) 1.13
Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest (2009) 1.11
Urologic management of spina bifida. Dev Disabil Res Rev (2010) 1.10
Racial/ethnic variation in the association of lipid-related genetic variants with blood lipids in the US adult population. Circ Cardiovasc Genet (2011) 1.10
Sweat-testing in preterm and full-term infants less than 6 weeks of age. Pediatr Pulmonol (2005) 1.10
Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature. J Urol (2008) 1.09
Developing Teaching Strategies in the EHR Era: A Survey of GME Experts. J Grad Med Educ (2016) 1.08
Variations in timing of surgery among boys who underwent orchidopexy for cryptorchidism. Pediatrics (2010) 1.08
Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am J Epidemiol (2010) 1.05
Infections in children and young adults with bone malignancies undergoing limb-sparing surgery. Cancer (2005) 1.04
Bone mineral density deficits in pediatric patients treated for sarcoma. Pediatr Blood Cancer (2008) 1.04
Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med (2009) 1.03
Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases. Eur J Hum Genet (2009) 1.02
Healthcare expenditures for privately insured people with cystic fibrosis. Pediatr Pulmonol (2009) 1.01
Patient registry analyses: seize the data, but caveat lector. J Pediatr (2008) 1.01
Nonoperative management of nonvascular grade IV blunt renal trauma in children: meta-analysis and systematic review. Urology (2009) 1.01
Racial/ethnic differences in association of fasting glucose-associated genomic loci with fasting glucose, HOMA-B, and impaired fasting glucose in the U.S. adult population. Diabetes Care (2010) 1.01
Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma. Pediatr Blood Cancer (2008) 0.99
Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet (2012) 0.99
Official American Thoracic Society technical standards: flexible airway endoscopy in children. Am J Respir Crit Care Med (2015) 0.98
Contemporary epidemiological trends in complex congenital genitourinary anomalies. J Urol (2013) 0.97
Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models. Eur J Hum Genet (2010) 0.97
Impact of pregnancy on women with cystic fibrosis. Chest (2006) 0.97
Reviewing definitions of urinary continence in the contemporary spina bifida literature: a call for clarity. J Pediatr Urol (2013) 0.96
Health inequalities and cystic fibrosis. BMJ (2011) 0.96
Second cancers in patients with the Ewing sarcoma family of tumours. Eur J Cancer (2008) 0.96
Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics (2007) 0.95
Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol (2011) 0.95
Influence of familial risk on diabetes risk-reducing behaviors among U.S. adults without diabetes. Diabetes Care (2011) 0.94
Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr (2012) 0.94
Regional variations in small intestinal submucosa evoke differences in inflammation with subsequent impact on tissue regeneration in the rat bladder augmentation model. BJU Int (2009) 0.93
Clinical and biologic significance of nuclear unrest in Wilms tumor. Cancer (2003) 0.93
Testing the feasibility of a National Spina Bifida Patient Registry. Birth Defects Res A Clin Mol Teratol (2012) 0.92
Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. J Infect Dis (2004) 0.91
Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention. Diabetes Res Clin Pract (2012) 0.89
Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses. Paediatr Anaesth (2007) 0.88
Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms. Pediatr Pulmonol (2012) 0.88
Prevalence, family history, and prevention of reported osteoporosis in U.S. women. Am J Prev Med (2008) 0.88
Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting? J Pediatr Urol (2006) 0.88
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr Pulmonol (2010) 0.87
The need for genetic variant naming standards in published abstracts of human genetic association studies. BMC Res Notes (2009) 0.87
Comparison of the US and Australian cystic fibrosis registries: the impact of newborn screening. Pediatrics (2012) 0.87
Adenocarcinoma of the cervix and vagina in pediatric patients. Pediatr Blood Cancer (2004) 0.86
Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis. Pediatr Pulmonol (2012) 0.86
Sacral neuromodulation in children with dysfunctional elimination syndrome: description of incisionless first stage and second stage without fluoroscopy. Urology (2009) 0.86
Leukocyte inflammatory response in a rat urinary bladder regeneration model using porcine small intestinal submucosa scaffold. Tissue Eng Part A (2009) 0.85
Patient and family impact of pediatric genitourinary diagnostic imaging tests. J Urol (2012) 0.85
Minimal contamination of the human peritoneum after transvesical incision. J Endourol (2009) 0.84
The gatekeeper disparity--why do some medical schools send more medical students into urology? J Urol (2010) 0.84
Association of urolithiasis with systemic conditions among pediatric patients at children's hospitals. J Urol (2012) 0.83
Do chief resident scores on the in-service examination predict their performance on the American Board of Urology Qualifying Examination? J Urol (2011) 0.83
Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex. Pediatr Blood Cancer (2010) 0.83
Does frank diabetes in first-degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes? Am J Obstet Gynecol (2009) 0.83
Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev (2008) 0.83
Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project. BMJ Qual Saf (2014) 0.83